EG18031A - Dihydropyridiniellactols,process for their preparation and their use as medicaments - Google Patents

Dihydropyridiniellactols,process for their preparation and their use as medicaments

Info

Publication number
EG18031A
EG18031A EG536/86A EG53686A EG18031A EG 18031 A EG18031 A EG 18031A EG 536/86 A EG536/86 A EG 536/86A EG 53686 A EG53686 A EG 53686A EG 18031 A EG18031 A EG 18031A
Authority
EG
Egypt
Prior art keywords
alkyl
opt
substd
interrupted
dihydropyridiniellactols
Prior art date
Application number
EG536/86A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of EG18031A publication Critical patent/EG18031A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
EG536/86A 1986-01-17 1986-08-25 Dihydropyridiniellactols,process for their preparation and their use as medicaments EG18031A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863601226 DE3601226A1 (de) 1986-01-17 1986-01-17 Dihydropyridinlactole, verfahren zur herstellung und ihre verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
EG18031A true EG18031A (en) 1991-11-30

Family

ID=6292033

Family Applications (1)

Application Number Title Priority Date Filing Date
EG536/86A EG18031A (en) 1986-01-17 1986-08-25 Dihydropyridiniellactols,process for their preparation and their use as medicaments

Country Status (25)

Country Link
US (1) US4721719A (cs)
EP (1) EP0235347B1 (cs)
JP (1) JPH0762018B2 (cs)
KR (1) KR870007179A (cs)
CN (2) CN1061528A (cs)
AT (1) ATE68184T1 (cs)
AU (1) AU587068B2 (cs)
CA (1) CA1293508C (cs)
CS (1) CS258492B2 (cs)
DD (1) DD268945A5 (cs)
DE (2) DE3601226A1 (cs)
DK (1) DK161252C (cs)
EG (1) EG18031A (cs)
ES (1) ES2009209A6 (cs)
FI (1) FI870151A7 (cs)
GR (1) GR862107B (cs)
HU (1) HU196804B (cs)
IL (1) IL81258A (cs)
NO (1) NO164597C (cs)
NZ (1) NZ217308A (cs)
PH (1) PH23676A (cs)
PL (2) PL149184B1 (cs)
PT (1) PT84120B (cs)
SU (1) SU1440345A3 (cs)
ZA (1) ZA865968B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3410645A1 (de) * 1984-03-23 1985-09-26 Bayer Ag, 5090 Leverkusen L-alkylsubstituierte 1,4-dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
JP2594809B2 (ja) * 1988-04-02 1997-03-26 日本ゼオン株式会社 タイヤトレッド用ゴム組成物
BR0206501A (pt) * 2001-01-17 2004-01-13 Amura Therapeutics Ltd Inibidores de cruzipaìna e outras cisteìna proteases
JP4860050B2 (ja) * 2001-04-23 2012-01-25 富士重工業株式会社 溶断装置による穿孔方法及び溶断装置
TW200519091A (en) * 2003-09-10 2005-06-16 Synta Pharmaceuticals Corp Dihydropyridine compounds for treating or preventing metabolic disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080220B1 (en) * 1981-11-17 1986-02-19 FISONS plc Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals
EP0111455A3 (de) * 1982-12-10 1984-07-25 Ciba-Geigy Ag Ungesättigte Lactone
DE3343658A1 (de) * 1983-12-02 1985-06-13 Bayer Ag, 5090 Leverkusen Hydroxy-tetrahydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
EP0235347B1 (de) 1991-10-09
US4721719A (en) 1988-01-26
DD268945A5 (de) 1989-06-14
CN1061528A (zh) 1992-06-03
HUT45255A (en) 1988-06-28
CN1019488B (zh) 1992-12-16
NZ217308A (en) 1988-11-29
PT84120A (en) 1987-02-01
EP0235347A2 (de) 1987-09-09
IL81258A (en) 1991-06-10
DK161252B (da) 1991-06-17
GR862107B (en) 1986-12-30
AU587068B2 (en) 1989-08-03
DE3681913D1 (de) 1991-11-14
CA1293508C (en) 1991-12-24
DK372586D0 (da) 1986-08-05
NO164597C (no) 1990-10-24
DE3601226A1 (de) 1987-07-23
JPS62169790A (ja) 1987-07-25
PT84120B (pt) 1989-07-31
PL149694B1 (en) 1990-03-31
ES2009209A6 (es) 1989-09-16
FI870151A0 (fi) 1987-01-15
IL81258A0 (en) 1987-08-31
DK372586A (da) 1987-07-18
NO865324L (no) 1987-07-20
PH23676A (en) 1989-09-27
PL261050A1 (en) 1988-07-07
FI870151A7 (fi) 1987-07-18
AU6323386A (en) 1987-07-23
EP0235347A3 (en) 1987-11-19
SU1440345A3 (ru) 1988-11-23
ZA865968B (en) 1987-03-25
PL271190A1 (en) 1989-01-23
PL149184B1 (en) 1990-01-31
CN86106735A (zh) 1987-07-29
HU196804B (en) 1989-01-30
ATE68184T1 (de) 1991-10-15
DK161252C (da) 1992-01-06
CS792386A2 (en) 1988-01-15
KR870007179A (ko) 1987-08-17
NO164597B (no) 1990-07-16
JPH0762018B2 (ja) 1995-07-05
CS258492B2 (en) 1988-08-16

Similar Documents

Publication Publication Date Title
MY101208A (en) Phenyl-piperazine anti-arrhythmia agents.
EG18031A (en) Dihydropyridiniellactols,process for their preparation and their use as medicaments
ZA852685B (en) Method of treating cardiac insufficiency
SE7609909L (sv) Nya penicilliner och forfarande for framstellning derav
PT85866A (en) Process for the preparation of therapeutic agents for the treatment of peptic ulcers containing 1,2,3,6-tetrahydro-3-methyl-1-(5-oxohexyl)-7-propyl-purine,6-dione and their derivatives
FR2473522B1 (cs)
DK0413278T3 (da) Anvendelse af xanthinderivater mod mavesår
ES2103218A1 (es) Derivados de piridona azetidinil substituidos con actividad antimicrobiana.
GR3002560T3 (en) 2-selenomethyl-1, 4-dihydropyridines, a process for the preparation thereof and pharmaceutical compositions containing them
FR2624120B1 (fr) Nouveaux sels organogermaniques utiles comme medicaments notamment comme activateurs des osteoblastes
EP0397615A3 (en) Pharmacologically active 2-substituted 3-(2-ethoxyethyl) imidazo [4,5-b] pyridines and pharmaceutical compositions containing them
HUT42677A (en) Herbicidal compositions comprising alpha-substituted acetophenone derivatives as active substance and process for preparing the active substances
GEP19980890B (en) Derivatives of N1-(1,2-Cis-halogeno¬-cyclopropyl) Substituted Pyridonecarbonic Acid
TH8703A (th) กรรมวิธีสำหรับเตรียม [5(6)-(เบนซิซอกซา-, เบนซิโซไทอะ-หรืออินดาโซล-3-อิล)-1h-เบนซิมิดาโซล-2-อิล]คาร์บาเมท